Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP:ADP antiporter activity	SLC25A4 SLC25A5 SLC25A6	9.75e-06	5	200	3	GO:0005471
GeneOntologyMolecularFunction	structural constituent of eye lens	CPOX CRYGB CRYGC CRYGD	8.87e-05	24	200	4	GO:0005212
GeneOntologyMolecularFunction	ADP transmembrane transporter activity	SLC25A4 SLC25A5 SLC25A6	1.54e-04	11	200	3	GO:0015217
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	ATR PRKDC	2.97e-04	3	200	2	GO:0035979
GeneOntologyMolecularFunction	ATP transmembrane transporter activity	SLC25A4 SLC25A5 SLC25A6	3.32e-04	14	200	3	GO:0005347
GeneOntologyBiologicalProcess	mitochondrial ADP transmembrane transport	SLC25A4 SLC25A5 SLC25A6	8.99e-06	5	201	3	GO:0140021
GeneOntologyCellularComponent	caveola	LRRK2 TSC2 ADRA1B DLC1 KCNMA1 PLD2 AKAP6 P2RY12 MAPK1	1.27e-06	111	201	9	GO:0005901
GeneOntologyCellularComponent	plasma membrane raft	LRRK2 TSC2 ADRA1B DLC1 KCNMA1 PLD2 AKAP6 P2RY12 PRKAR2A MAPK1	1.64e-06	147	201	10	GO:0044853
GeneOntologyCellularComponent	membrane raft	LRRK2 TSC2 ADRA1B DLC1 KCNMA1 PLD2 GP2 AKAP6 SLC25A4 SLC25A5 P2RY12 PRKAR2A MAPK1	5.15e-05	362	201	13	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	LRRK2 TSC2 ADRA1B DLC1 KCNMA1 PLD2 GP2 AKAP6 SLC25A4 SLC25A5 P2RY12 PRKAR2A MAPK1	5.44e-05	364	201	13	GO:0098857
GeneOntologyCellularComponent	brahma complex	DPF3 SMARCC1 SMARCC2	2.95e-04	14	201	3	GO:0035060
GeneOntologyCellularComponent	nBAF complex	DPF3 SMARCC1 SMARCC2	4.47e-04	16	201	3	GO:0071565
GeneOntologyCellularComponent	COPII vesicle coat	SEC24D PEF1 SEC24B	4.47e-04	16	201	3	GO:0030127
Domain	ARM-type_fold	ATR LRRK2 TSC2 USP9Y INSC RIPOR1 RIC8A ARMC6 DOCK8 USP24 API5 ARFGEF3 PRKDC HTT	1.29e-05	339	194	14	IPR016024
Domain	ARM-like	ATR LRRK2 TSC2 USP9Y INSC RIPOR1 RIC8A ARMC6 DOCK8 API5 PRKDC HTT	2.66e-05	270	194	12	IPR011989
Domain	Growth_fac_rcpt_	EPHB6 LAMA1 FBLN1 LAMA5 CUBN SCUBE3 LTBP2 EPHA1 PROS1	3.75e-05	156	194	9	IPR009030
Domain	SMARCC_C	SMARCC1 SMARCC2	1.07e-04	2	194	2	IPR032451
Domain	SMARCC_N	SMARCC1 SMARCC2	1.07e-04	2	194	2	IPR032450
Domain	SWIRM-assoc	SMARCC1 SMARCC2	1.07e-04	2	194	2	IPR032448
Domain	SWIRM-assoc_2	SMARCC1 SMARCC2	1.07e-04	2	194	2	PF16496
Domain	SWIRM-assoc_1	SMARCC1 SMARCC2	1.07e-04	2	194	2	PF16495
Domain	SWIRM-assoc_3	SMARCC1 SMARCC2	1.07e-04	2	194	2	PF16498
Domain	-	ATR LRRK2 TSC2 INSC RIPOR1 RIC8A ARMC6 API5 PRKDC HTT	1.13e-04	222	194	10	1.25.10.10
Domain	CUB	PDGFC CUBN ADGRG6 PDGFD SCUBE3	1.51e-04	49	194	5	PF00431
Domain	CUB	PDGFC CUBN ADGRG6 PDGFD SCUBE3	1.67e-04	50	194	5	SM00042
Domain	-	PDGFC CUBN ADGRG6 PDGFD SCUBE3	2.01e-04	52	194	5	2.60.120.290
Domain	CUB	PDGFC CUBN ADGRG6 PDGFD SCUBE3	2.20e-04	53	194	5	PS01180
Domain	Mit_uncoupling	SLC25A4 SLC25A5 SLC25A6	2.27e-04	12	194	3	IPR002030
Domain	FN3	EPHB6 MDGA2 TYRO3 FNDC11 ASTN2 FLRT2 SDK2 PTPRU EPHA1	2.41e-04	199	194	9	PS50853
Domain	EGF-like_dom	LAMA1 FBLN1 FCGBP GP2 LAMA5 CUBN TECTA SCUBE3 LTBP2 PROS1	2.86e-04	249	194	10	IPR000742
Domain	CUB_dom	PDGFC CUBN ADGRG6 PDGFD SCUBE3	3.10e-04	57	194	5	IPR000859
Domain	TILa_dom	FCGBP TECTA	3.20e-04	3	194	2	IPR025615
Domain	TILa	FCGBP TECTA	3.20e-04	3	194	2	PF12714
Domain	FN3_dom	EPHB6 MDGA2 TYRO3 FNDC11 ASTN2 FLRT2 SDK2 PTPRU EPHA1	3.46e-04	209	194	9	IPR003961
Domain	Beta/gamma_crystallin	CRYGB CRYGC CRYGD	4.58e-04	15	194	3	IPR001064
Domain	PI3/4_kinase_CS	ATR PI4KB PRKDC	4.58e-04	15	194	3	IPR018936
Domain	CRYSTALLIN_BETA_GAMMA	CRYGB CRYGC CRYGD	4.58e-04	15	194	3	PS50915
Domain	Crystall	CRYGB CRYGC CRYGD	4.58e-04	15	194	3	PF00030
Domain	XTALbg	CRYGB CRYGC CRYGD	4.58e-04	15	194	3	SM00247
Domain	EGF_2	LAMA1 FBLN1 ASTN2 GP2 LAMA5 CUBN SCUBE3 LTBP2 EPHA1 PROS1	4.67e-04	265	194	10	PS01186
Domain	Kinase-like_dom	EPHB6 ATR LRRK2 WDR81 TYK2 TYRO3 PI4KB ROR2 STK16 LIMK2 SMARCC1 PRKDC MAPK1 PEAK1 EPHA1	5.58e-04	542	194	15	IPR011009
Domain	-	ATR PI4KB PRKDC	5.59e-04	16	194	3	1.10.1070.11
Domain	PI3Kc	ATR PI4KB PRKDC	5.59e-04	16	194	3	SM00146
Domain	PseudoU_synth_2	RPUSD3 RPUSD2	6.35e-04	4	194	2	PF00849
Domain	PSI_RLU	RPUSD3 RPUSD2	6.35e-04	4	194	2	PS01129
Domain	PsdUridine_synth_RsuA/RluD	RPUSD3 RPUSD2	6.35e-04	4	194	2	IPR006145
Domain	G_crystallin-rel	CRYGB CRYGC CRYGD	8.03e-04	18	194	3	IPR011024
Domain	PI3_PI4_kinase	ATR PI4KB PRKDC	8.03e-04	18	194	3	PF00454
Domain	PI3_4_KINASE_1	ATR PI4KB PRKDC	8.03e-04	18	194	3	PS00915
Domain	PI3_4_KINASE_2	ATR PI4KB PRKDC	8.03e-04	18	194	3	PS00916
Domain	PI3/4_kinase_cat_dom	ATR PI4KB PRKDC	8.03e-04	18	194	3	IPR000403
Domain	PI3_4_KINASE_3	ATR PI4KB PRKDC	8.03e-04	18	194	3	PS50290
Domain	EGF	LAMA1 FBLN1 FCGBP LAMA5 CUBN TECTA SCUBE3 LTBP2 PROS1	8.05e-04	235	194	9	SM00181
Domain	Laminin_domII	LAMA1 LAMA5	1.05e-03	5	194	2	IPR010307
Domain	Laminin_aI	LAMA1 LAMA5	1.05e-03	5	194	2	IPR009254
Domain	Laminin_I	LAMA1 LAMA5	1.05e-03	5	194	2	PF06008
Domain	Laminin_II	LAMA1 LAMA5	1.05e-03	5	194	2	PF06009
Domain	FATC	ATR PRKDC	1.05e-03	5	194	2	PF02260
Domain	Ig-like_fold	EPHB6 MDGA2 SIRPB1 CD83 PLXNB2 TYRO3 SIRPD FNDC11 MICB ASTN2 FLRT2 SDK2 TRB ROR2 PTPRU CD1C EPHA1	1.14e-03	706	194	17	IPR013783
Domain	EGF_1	LAMA1 FBLN1 ASTN2 GP2 LAMA5 CUBN SCUBE3 LTBP2 PROS1	1.43e-03	255	194	9	PS00022
Domain	-	EPHB6 MDGA2 SIRPB1 CD83 PLXNB2 TYRO3 SIRPD FNDC11 MICB ASTN2 FLRT2 SDK2 ROR2 PTPRU CD1C EPHA1	1.56e-03	663	194	16	2.60.40.10
Domain	Sec23/24_helical_dom	SEC24D SEC24B	1.57e-03	6	194	2	IPR006900
Domain	Sec23_24_beta_S	SEC24D SEC24B	1.57e-03	6	194	2	IPR012990
Domain	zf-Sec23_Sec24	SEC24D SEC24B	1.57e-03	6	194	2	PF04810
Domain	Sec23_trunk	SEC24D SEC24B	1.57e-03	6	194	2	PF04811
Domain	Sec23_helical	SEC24D SEC24B	1.57e-03	6	194	2	PF04815
Domain	SWIRM	SMARCC1 SMARCC2	1.57e-03	6	194	2	PS50934
Domain	FAT	ATR PRKDC	1.57e-03	6	194	2	PS51189
Domain	FATC	ATR PRKDC	1.57e-03	6	194	2	PS51190
Domain	Sec23_BS	SEC24D SEC24B	1.57e-03	6	194	2	PF08033
Domain	FAT	ATR PRKDC	1.57e-03	6	194	2	PF02259
Domain	SWIRM	SMARCC1 SMARCC2	1.57e-03	6	194	2	PF04433
Domain	PIK-rel_kinase_FAT	ATR PRKDC	1.57e-03	6	194	2	IPR003151
Domain	FATC_dom	ATR PRKDC	1.57e-03	6	194	2	IPR003152
Domain	SWIRM	SMARCC1 SMARCC2	1.57e-03	6	194	2	IPR007526
Domain	Sec23/24_trunk_dom	SEC24D SEC24B	1.57e-03	6	194	2	IPR006896
Domain	Znf_Sec23_Sec24	SEC24D SEC24B	1.57e-03	6	194	2	IPR006895
Domain	PIK_FAT	ATR PRKDC	1.57e-03	6	194	2	IPR014009
Domain	FATC	ATR PRKDC	1.57e-03	6	194	2	SM01343
Domain	EGF-like_CS	LAMA1 FBLN1 GP2 LAMA5 CUBN SCUBE3 LTBP2 EPHA1 PROS1	1.67e-03	261	194	9	IPR013032
Domain	EGF_CA	FBLN1 CUBN SCUBE3 LTBP2 PROS1	2.03e-03	86	194	5	PF07645
Domain	Ephrin_rec_like	EPHB6 SCUBE3 EPHA1	2.14e-03	25	194	3	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB6 SCUBE3 EPHA1	2.14e-03	25	194	3	IPR011641
Domain	Pkinase_Tyr	EPHB6 TYK2 TYRO3 ROR2 LIMK2 EPHA1	2.30e-03	129	194	6	PF07714
Domain	LAMININ_IVA	LAMA1 LAMA5	2.88e-03	8	194	2	PS51115
Domain	Laminin_B	LAMA1 LAMA5	2.88e-03	8	194	2	PF00052
Domain	LamB	LAMA1 LAMA5	2.88e-03	8	194	2	SM00281
Domain	Laminin_IV	LAMA1 LAMA5	2.88e-03	8	194	2	IPR000034
Domain	Aden_trnslctor	SLC25A4 SLC25A5 SLC25A6	2.99e-03	28	194	3	IPR002113
Domain	Galactose-bd-like	EPHB6 LAMA1 LAMA5 PTPRU EPHA1	2.99e-03	94	194	5	IPR008979
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM	SLC25A4 SLC25A5 SLC25A6 GRIN2A HTT	1.19e-06	19	147	5	M47677
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM	SLC25A4 SLC25A5 SLC25A6 GRIN2A	1.42e-05	15	147	4	M47691
Pathway	KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM	SLC25A4 SLC25A5 SLC25A6 GRIN2A	3.10e-05	18	147	4	M47761
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	SLC25A4 SLC25A5 SLC25A6 HTT	8.61e-05	23	147	4	M47676
Pathway	KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY	CACNA1I SLC25A4 SLC25A5 SLC25A6	8.61e-05	23	147	4	M47666
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006	SLC25A4 SLC25A5 SLC25A6	1.26e-04	10	147	3	M47694
Pubmed	Expression of leucine-rich repeat kinase 2 (LRRK2) inhibits the processing of uMtCK to induce cell death in a cell culture model system.	LRRK2 SLC25A4 SLC25A5 SLC25A6	3.97e-08	7	204	4	21370995
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	THSD4 FREM2 DNAJC10 SLC25A5 LAMA5 OGDH PPP1R10 LMNA SMARCC2 PRKDC SNRNP200	8.05e-08	219	204	11	31353912
Pubmed	The human mitochondrial ADP/ATP carriers: kinetic properties and biogenesis of wild-type and mutant proteins in the yeast S. cerevisiae.	SLC25A4 SLC25A5 SLC25A6	1.99e-07	3	204	3	12450408
Pubmed	The gamma-crystallins and human cataracts: a puzzle made clearer.	CRYGB CRYGC CRYGD	1.99e-07	3	204	3	10521291
Pubmed	Methylation and carbamylation of human gamma-crystallins.	CRYGB CRYGC CRYGD	1.99e-07	3	204	3	12876325
Pubmed	DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase.	SLC25A4 SLC25A5 SLC25A6	1.99e-07	3	204	3	2541251
Pubmed	Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver.	SLC25A4 SLC25A5 SLC25A6	1.99e-07	3	204	3	2829183
Pubmed	Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.	SEC24D PEF1 SEC24B CUL1 SMARCC1 SMARCC2	4.85e-07	50	204	6	27716508
Pubmed	The mouse eye lens obsolescence (Elo) mutant: studies on crystallin gene expression and linkage analysis between the mutant locus and the gamma-crystallin genes.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	3428594
Pubmed	Homology models of human gamma-crystallins: structural study of the extensive charge network in gamma-crystallins.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	12507494
Pubmed	Differential Expression of ADP/ATP Carriers as a Biomarker of Metabolic Remodeling and Survival in Kidney Cancers.	SLC25A4 SLC25A5 SLC25A6	7.92e-07	4	204	3	33396658
Pubmed	Differential regulation of gamma-crystallin genes during mouse lens development.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	3792630
Pubmed	The C-terminal domain of Kv1.3 regulates functional interactions with the KCNE4 subunit.	SEC24D KCNE4 SEC24B	7.92e-07	4	204	3	27802162
Pubmed	Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	12011157
Pubmed	Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	15037589
Pubmed	Assignment of the human gamma-crystallin gene cluster (CRYG) to the long arm of chromosome 2, region q33-36.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	3011643
Pubmed	Temporal regulation of six crystallin transcripts during mouse lens development.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	1623964
Pubmed	Partially folded aggregation intermediates of human gammaD-, gammaC-, and gammaS-crystallin are recognized and bound by human alphaB-crystallin chaperone.	CRYGB CRYGC CRYGD	7.92e-07	4	204	3	20621668
Pubmed	PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential.	PLXNB2 TYK2 CYFIP1 ROR2 PRKAR2A PEAK1 SOS2	1.43e-06	94	204	7	32062451
Pubmed	The crystallins: genes, proteins and diseases.	CRYGB CRYGC CRYGD	1.97e-06	5	204	3	9426193
Pubmed	The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.	NR3C1 SMARCC1 SMARCC2	1.97e-06	5	204	3	18086889
Pubmed	Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1.	FBLN1 ACAN DCHS1	1.97e-06	5	204	3	16061471
Pubmed	Structure of the crystallins.	CRYGB CRYGC CRYGD	1.97e-06	5	204	3	10627816
Pubmed	Human gamma-crystallin genes. A gene family on its way to extinction.	CRYGB CRYGC CRYGD	3.93e-06	6	204	3	2258929
Pubmed	The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore.	SLC25A4 SLC25A5 SLC25A6	3.93e-06	6	204	3	10620603
Pubmed	Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family.	CRYGB CRYGC CRYGD	3.93e-06	6	204	3	3670288
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	HBS1L MCMBP PGGT1B USP19 SEC24D CYFIP1 UFD1 PLA2G4A RIPOR1 RIC8A ANKRD40 CUL1 AMPD2 USP24 API5 NR3C1 RFC4 LMNA RPUSD2 PRKAR2A PRKDC BUB3 SNRNP200 HTT	5.34e-06	1455	204	24	22863883
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	HBS1L TYK2 AFG3L2 CUL1 SLC25A4 SLC25A5 SLC25A6 RFC4 SMARCC1 SMARCC2 PRKDC BUB3 SNRNP200	6.78e-06	486	204	13	30940648
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	EPHB6 TYRO3 TEKT2 MICB ROR2 API5 PTPRU IDH3G STPG4 EDEM1 KRTAP15-1 EPHA1	8.00e-06	420	204	12	28065597
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	CYFIP1 DLC1 ARHGAP31 BRPF1 DSG1 DOCK8 API5 ECH1 PPP1R10 LMNA SMARCC1 PRKAR2A SMARCC2 MAPK1 PEAK1 BUB3 DEPDC1B SOS2	8.70e-06	916	204	18	32203420
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HBS1L MCMBP TSC2 PEF1 CYFIP1 DNAJC10 UFD1 AFG3L2 AMPD2 SLC25A4 DSG1 SLC25A5 SLC25A6 USP24 RFC4 ECH1 LMNA SMARCC1 SMARCC2 PRKDC MAPK1 BUB3 SNRNP200	1.07e-05	1415	204	23	28515276
Pubmed	Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.	ATR DCLRE1C PRKDC	1.09e-05	8	204	3	15456891
Pubmed	TSPO ligands stimulate ZnPPIX transport and ROS accumulation leading to the inhibition of P. falciparum growth in human blood.	SLC25A4 SLC25A5 SLC25A6	1.09e-05	8	204	3	27641616
Pubmed	Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease.	LRRK2 SLC25A4 SLC25A5 SLC25A6	1.11e-05	24	204	4	24725412
Pubmed	Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.	ATR USP9Y CUL1 RFC4 SBF2 PRKDC	1.29e-05	87	204	6	17148452
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	MCMBP TSC2 CYFIP1 DNAJC10 UFD1 AFG3L2 ARMC6 CUL1 MED6 SLC25A4 DSG1 SLC25A5 SLC25A6 CPOX IDH3G RFC4 PRKAR2A PRKDC MAPK1 BUB3 SNRNP200	1.78e-05	1257	204	21	37317656
Pubmed	Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice.	CRYGB CRYGC CRYGD	2.31e-05	10	204	3	9512512
Pubmed	Regulation of lens fiber cell differentiation by transcription factor c-Maf.	CRYGB CRYGC CRYGD	2.31e-05	10	204	3	10383433
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NOL4 USP9Y DNAJC10 USP12 SLC25A4 SLC25A5 SLC25A6 INO80 RFC4 OGDH PPP1R10 LMNA HELZ2 SMARCC1 SMARCC2 PRKDC BUB3 SNRNP200 ZMYM3	2.32e-05	1082	204	19	38697112
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	CYFIP1 UFD1 RIPOR1 SLC25A4 DSG1 SLC25A5 SLC25A6 LAMA5 IDH3G LMNA C18orf63 HELZ2 PRKDC MAPK1 BUB3 SOS2	2.36e-05	803	204	16	36517590
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	HBS1L PGGT1B ARID5B TASOR ANKRD40 AKAP6 LARGE2 AMPD2 CCDC127 INO80 PRAMEF17 CUBN TBCCD1 SETD5 SBF2 SOCS5 SMARCC1 MAPK1 PEAK1	2.38e-05	1084	204	19	11544199
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	USP19 CYFIP1 DNAJC10 RIC8A CUL1 SLC25A5 USP24 API5 LMNA SMARCC1 PRKAR2A PRKDC BUB3 SNRNP200	2.74e-05	638	204	14	33239621
Pubmed	Mammalian SWI/SNF collaborates with a polycomb-associated protein to regulate male germline transcription in the mouse.	ATR DPF3 SMARCC1 SMARCC2	2.79e-05	30	204	4	31043422
Pubmed	BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation.	NR3C1 SMARCC1 SMARCC2	3.17e-05	11	204	3	12917342
Pubmed	Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.	ATR MLST8 PRKDC	3.17e-05	11	204	3	20427287
Pubmed	Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions.	CRYGB CRYGC CRYGD	3.17e-05	11	204	3	10595510
Pubmed	Shotgun identification of protein modifications from protein complexes and lens tissue.	CRYGB CRYGC CRYGD	3.17e-05	11	204	3	12060738
Pubmed	Multiple developmental defects derived from impaired recruitment of ASC-2 to nuclear receptors in mice: implication for posterior lenticonus with cataract.	CRYGB CRYGC CRYGD	3.17e-05	11	204	3	12446761
Pubmed	E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.	CRYGB CRYGC CRYGD	3.17e-05	11	204	3	11146559
Pubmed	PDGF-C and PDGF-D in ocular diseases.	PDGFC PDGFD	3.42e-05	2	204	2	29079201
Pubmed	A locus for a human hereditary cataract is closely linked to the gamma-crystallin gene family.	CRYGC CRYGD	3.42e-05	2	204	2	3025877
Pubmed	The laminin response in inflammatory bowel disease: protection or malignancy?	LAMA1 LAMA5	3.42e-05	2	204	2	25347196
Pubmed	The Swi3 protein plays a unique role in regulating respiration in eukaryotes.	SMARCC1 SMARCC2	3.42e-05	2	204	2	27190130
Pubmed	DNA structure-specific priming of ATR activation by DNA-PKcs.	ATR PRKDC	3.42e-05	2	204	2	23897887
Pubmed	Changes in the expression of the human adenine nucleotide translocase isoforms condition cellular metabolic/proliferative status.	SLC25A5 SLC25A6	3.42e-05	2	204	2	26842067
Pubmed	DNA damage induces nuclear envelope rupture through ATR-mediated phosphorylation of lamin A/C.	ATR LMNA	3.42e-05	2	204	2	37832547
Pubmed	[Correlation between ultrastructural changes of glomerular basement membrane and abnormal distribution of laminins in patients with Alport's syndrome].	LAMA1 LAMA5	3.42e-05	2	204	2	20019771
Pubmed	Mouse LIM-kinase 2 gene: cDNA cloning, genomic organization, and tissue-specific expression of two alternatively initiated transcripts.	KCNMA1 LIMK2	3.42e-05	2	204	2	9441759
Pubmed	A biochemically defined system for mammalian nonhomologous DNA end joining.	DCLRE1C PRKDC	3.42e-05	2	204	2	15574326
Pubmed	Structural analysis of the basal state of the Artemis:DNA-PKcs complex.	DCLRE1C PRKDC	3.42e-05	2	204	2	35801871
Pubmed	The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps.	DCLRE1C PRKDC	3.42e-05	2	204	2	15936993
Pubmed	A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions.	SLC25A4 SLC25A6	3.42e-05	2	204	2	12112115
Pubmed	The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice.	DCLRE1C PRKDC	3.42e-05	2	204	2	17686847
Pubmed	Extent to which hairpin opening by the Artemis:DNA-PKcs complex can contribute to junctional diversity in V(D)J recombination.	DCLRE1C PRKDC	3.42e-05	2	204	2	17932067
Pubmed	Acidic glycosaminoglycans and laminin-1 in renal corpuscles of mutant blebs (my) and control mice.	LAMA1 FREM2	3.42e-05	2	204	2	9302549
Pubmed	Hippocalcin increases phospholipase D2 expression through extracellular signal-regulated kinase activation and lysophosphatidic acid potentiates the hippocalcin-induced phospholipase D2 expression.	PLD2 MAPK1	3.42e-05	2	204	2	16294323
Pubmed	The matrix proteins aggrecan and fibulin-1 play a key role in determining aortic stiffness.	FBLN1 ACAN	3.42e-05	2	204	2	29867203
Pubmed	The metallo-beta-lactamase/beta-CASP domain of Artemis constitutes the catalytic core for V(D)J recombination.	DCLRE1C PRKDC	3.42e-05	2	204	2	14744996
Pubmed	Apoptotic and anti-proliferative effects of all-trans retinoic acid. Adenine nucleotide translocase sensitizes HeLa cells to all-trans retinoic acid.	SLC25A4 SLC25A6	3.42e-05	2	204	2	16556444
Pubmed	Structural basis of an ERAD pathway mediated by the ER-resident protein disulfide reductase ERdj5.	DNAJC10 EDEM1	3.42e-05	2	204	2	21329881
Pubmed	Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes.	SLC25A4 SLC25A5	3.42e-05	2	204	2	10974536
Pubmed	Nucleotide sequence of the rat gamma-crystallin gene region and comparison with an orthologous human region.	CRYGB CRYGC	3.42e-05	2	204	2	2777080
Pubmed	A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.	DCLRE1C PRKDC	3.42e-05	2	204	2	19075392
Pubmed	Stretch-induced ERK2 phosphorylation requires PLA2 activity in skeletal myotubes.	PLA2G4A MAPK1	3.42e-05	2	204	2	19524551
Pubmed	cPLA2 is phosphorylated and activated by MAP kinase.	PLA2G4A MAPK1	3.42e-05	2	204	2	8381049
Pubmed	Sequence-specific DNA binding and transcription factor phosphorylation by Ku Autoantigen/DNA-dependent protein kinase. Phosphorylation of Ser-527 of the rat glucocorticoid receptor.	NR3C1 PRKDC	3.42e-05	2	204	2	9038175
Pubmed	Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.	FBXO39 RNF17	3.42e-05	2	204	2	24377578
Pubmed	Artemis phosphorylated by DNA-dependent protein kinase associates preferentially with discrete regions of chromatin.	DCLRE1C PRKDC	3.42e-05	2	204	2	16600297
Pubmed	Defects in cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations.	LMNA MAPK1	3.42e-05	2	204	2	19524666
Pubmed	CCL8 Promotes Postpartum Breast Cancer by Recruiting M2 Macrophages.	CCL8 PRKDC	3.42e-05	2	204	2	32535027
Pubmed	Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression.	PDGFC PDGFD	3.42e-05	2	204	2	18573494
Pubmed	Functional and biochemical dissection of the structure-specific nuclease ARTEMIS.	DCLRE1C PRKDC	3.42e-05	2	204	2	15071507
Pubmed	The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore.	SLC25A4 SLC25A5	3.42e-05	2	204	2	14749836
Pubmed	Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination.	DCLRE1C PRKDC	3.42e-05	2	204	2	11955432
Pubmed	The Dtk receptor tyrosine kinase, which binds protein S, is expressed during hematopoiesis.	TYRO3 PROS1	3.42e-05	2	204	2	8641360
Pubmed	DNA-PK autophosphorylation facilitates Artemis endonuclease activity.	DCLRE1C PRKDC	3.42e-05	2	204	2	16874298
Pubmed	Platelet-derived growth factor-C and -D in the cardiovascular system and diseases.	PDGFC PDGFD	3.42e-05	2	204	2	28965749
Pubmed	Two human gamma-crystallin genes are linked and riddled with Alu-repeats.	CRYGB CRYGC	3.42e-05	2	204	2	4065573
Pubmed	Role of adenine nucleotide translocator 1 in mtDNA maintenance.	SLC25A4 SLC25A6	3.42e-05	2	204	2	10926541
Pubmed	Artemis deficiency confers a DNA double-strand break repair defect and Artemis phosphorylation status is altered by DNA damage and cell cycle progression.	DCLRE1C PRKDC	3.42e-05	2	204	2	15811628
Pubmed	Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission.	LAMA1 LAMA5	3.42e-05	2	204	2	28544784
Pubmed	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	CD83 IL17RB	3.42e-05	2	204	2	33455090
Pubmed	A promoter polymorphism of lamin A/C gene is an independent genetic predisposition to arterial stiffness in a Japanese general population (the Tanno and Sobetsu study).	LAMA1 LMNA	3.42e-05	2	204	2	19672032
Pubmed	A crystallin mutant cataract with mineral deposits.	CRYGB CRYGC	3.42e-05	2	204	2	37331601
Pubmed	Deficiency in the mouse mitochondrial adenine nucleotide translocator isoform 2 gene is associated with cardiac noncompaction.	SLC25A4 SLC25A5	3.42e-05	2	204	2	27048932
Pubmed	cDNA sequence of a human skeletal muscle ADP/ATP translocator: lack of a leader peptide, divergence from a fibroblast translocator cDNA, and coevolution with mitochondrial DNA genes.	SLC25A4 SLC25A6	3.42e-05	2	204	2	2823266
Pubmed	Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts.	CRYGB CRYGD	3.42e-05	2	204	2	12676897
Pubmed	A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family.	SLC25A4 SLC25A6	3.42e-05	2	204	2	11756613
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	NDE1 STYXL2 TSC2 TEKT2 CYFIP1 PI4KB SEC24B AFG3L2 RIPOR1 MLST8 AMPD2 SLC25A4 RFC4 PPP1R10 GTF2H1 SETD5 MRPL38 BUB3 SNRNP200 DEPDC1B EDRF1	3.67e-05	1321	204	21	27173435
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HBS1L RTEL1 ASTN2 FLRT2 TASOR GBA2 MSL2 SBF2 SOCS5 HELZ2 PEAK1 SNRNP200	3.86e-05	493	204	12	15368895
GeneFamily	Beta-gamma crystallins	CRYGB CRYGC CRYGD	1.62e-04	15	132	3	1359
GeneFamily	Fibronectin type III domain containing	EPHB6 TYRO3 ASTN2 FLRT2 SDK2 PTPRU EPHA1	1.74e-04	160	132	7	555
GeneFamily	RNA pseudouridylate synthase domain containing	RPUSD3 RPUSD2	3.14e-04	4	132	2	727
GeneFamily	CD molecules\|V-set domain containing\|C1-set domain containing\|Signal regulatory proteins	SIRPB1 SIRPD	5.21e-04	5	132	2	747
GeneFamily	Ubiquitin specific peptidases	USP9Y USP19 USP12 USP24	7.43e-04	56	132	4	366
Coexpression	CHICAS_RB1_TARGETS_GROWING	THSD4 DCN FBLN1 KCNMA1 RFC4 ADGRG6 LMNA DPF3 PDGFD SCUBE3 SMARCC1 LTBP2	3.66e-07	242	199	12	M2128
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	DCN PLXNB2 USP19 PI4KB PLD2 TASOR ATP10D LIMK2 GTF2H1 DPF3 SMARCC1 PRKAR2A SMARCC2	9.54e-06	389	199	13	M6520
Coexpression	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN	TSC2 QSOX1 MLST8 PDGFC DSG1 ADGRG6 NPRL2 SNRNP200 HTT	2.01e-05	196	199	9	M6174
Coexpression	GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP	QSOX1 MLST8 PDGFC DSG1 ECH1 NPRL2 PIK3R6 MRPL38 HTT	2.36e-05	200	199	9	M6140
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#4	TYRO3 FREM2 TEKT2 SLAIN1 GGACT LARGE2 WSCD1 PEX5L	5.52e-06	104	196	8	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B KCNE4 DLC1 PLA2G4A FLRT2 NEURL1B ROR2 GRIN2A	1.70e-09	194	204	11	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B KCNE4 DLC1 PLA2G4A FLRT2 NEURL1B ROR2 GRIN2A	1.70e-09	194	204	11	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 DCN FREM2 KCNMA1 FLRT2 PDGFC AKAP6 ROR2 ADGRG6	2.24e-07	188	204	9	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B DLC1 PLA2G4A FLRT2 ROR2 GRIN2A	2.35e-07	189	204	9	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B DLC1 PLA2G4A FLRT2 ROR2 GRIN2A	2.35e-07	189	204	9	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B DLC1 PLA2G4A FLRT2 ROR2 GRIN2A	2.57e-07	191	204	9	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B DLC1 PLA2G4A FLRT2 ROR2 GRIN2A	2.57e-07	191	204	9	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 NEURL1B ROR2 GRIN2A	2.93e-07	194	204	9	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 NEURL1B ROR2 GRIN2A	2.93e-07	194	204	9	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN SEC24D FBLN1 DLC1 PLA2G4A NEURL1B ATP10D	3.06e-07	195	204	9	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN SEC24D FBLN1 DLC1 PLA2G4A NEURL1B ATP10D	3.06e-07	195	204	9	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN FBLN1 DLC1 PLA2G4A FLRT2 NEURL1B GRIN2A	3.33e-07	197	204	9	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN FBLN1 DLC1 PLA2G4A FLRT2 NEURL1B GRIN2A	3.33e-07	197	204	9	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PENK PLPPR1 ADRA1B KCNE4 AGTR2 ASIC4 LAMA5 DPF3	3.84e-07	146	204	8	47368f981180ca6a8c81a50f7f9430f12456f609
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN SEC24D FBLN1 PLA2G4A FLRT2 ROR2 GRIN2A	1.16e-06	169	204	8	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 CD83 PLPPR1 F11 GP2 AKAP6 USP24 ARFGEF3	1.87e-06	180	204	8	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 DCN KCNMA1 FLRT2 PDGFC AKAP6 ROR2 ADGRG6	2.38e-06	186	204	8	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	NOL4 DCN TYRO3 KCNE4 FLRT2 WSCD1 ROR2 LTBP2	2.48e-06	187	204	8	e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD4 ADRA1B KCNE4 PLA2G4A FLRT2 ROR2 ZDBF2 GRIN2A	2.48e-06	187	204	8	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 CD83 PLPPR1 F11 GP2 SLC25A4 SLC25A5 ARFGEF3	2.48e-06	187	204	8	85e58a312fc325e4063a2d250666b99b8f99beb6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 CD83 PLPPR1 F11 GP2 SLC25A4 SLC25A5 ARFGEF3	2.48e-06	187	204	8	52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PENK ACAN KCNMA1 FLRT2 PDGFC SDK2 DOCK8 SCUBE3	2.90e-06	191	204	8	273c4a757292a9301de0eaeacdec91c9866be229
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PENK ACAN KCNMA1 FLRT2 PDGFC SDK2 DOCK8 SCUBE3	2.90e-06	191	204	8	f9a46956778a8773d6656340ecf5d218376d79c2
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 GRIN2A ATP10D	3.02e-06	192	204	8	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 ROR2 GRIN2A	3.02e-06	192	204	8	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 GRIN2A ATP10D	3.02e-06	192	204	8	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 ROR2 GRIN2A	3.02e-06	192	204	8	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B DLC1 PLA2G4A NEURL1B GRIN2A	3.13e-06	193	204	8	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN FBLN1 DLC1 PLA2G4A GRIN2A ATP10D	3.13e-06	193	204	8	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN FBLN1 DLC1 PLA2G4A GRIN2A ATP10D	3.13e-06	193	204	8	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 NEURL1B GRIN2A	3.26e-06	194	204	8	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN FBLN1 CYFIP1 P2RY12 USP24 NR3C1 PEAK1 PROS1	3.38e-06	195	204	8	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 NEURL1B GRIN2A	3.38e-06	195	204	8	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PENK PLXNB2 FREM2 KCNE4 DLC1 ASIC4 PDGFC LAMA5	3.51e-06	196	204	8	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN SEC24D FBLN1 DLC1 PLA2G4A ATP10D	3.51e-06	196	204	8	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN SEC24D FBLN1 DLC1 PLA2G4A ATP10D	3.51e-06	196	204	8	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 APCDD1 DCN FBLN1 DLC1 PLA2G4A GRIN2A ATP10D	3.65e-06	197	204	8	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	THSD4 DCN FBLN1 DLC1 PLA2G4A FLRT2 ROR2 GRIN2A	3.93e-06	199	204	8	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MOCS3 SLAIN1 SNURF LARGE2 SDK2 ATP10D TRMT44	7.82e-06	156	204	7	7ece590fd8f29382e349dd0e5e016d2926aeb518
ToppCell	Control-B_naive-12\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MOCS3 SLAIN1 SNURF BCL2L13 SDK2 ATP10D TRMT44	8.15e-06	157	204	7	4803f601c1ba43260aa09172acc7964aac2c8ccf
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	THSD4 SIRPB1 FREM2 MOCS3 IL17RB ARMC6 LAMA5	8.85e-06	159	204	7	24f87c666eff10c1844c900ffd7ad49fa9f80481
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DLC1 SDK2 TRB PTPRU PEX5L GALNT9 PEAK1	1.00e-05	162	204	7	4d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCell	NS-moderate-d_16-33-Myeloid-Mast_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RTEL1 DLC1 ASIC4 CCL23 CRYGD PIK3R6 DCHS1	1.08e-05	164	204	7	35c673380f75cb4bfe080089bc723c4373bcc7a5
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPHB6 PLA2G4A FLRT2 ROR2 PEX5L ADGRG6 GALNT9	1.08e-05	164	204	7	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PENK PLPPR1 ASIC4 LARGE2 WSCD1 SDK2 ROR2	1.32e-05	169	204	7	eb3b8e473192c4b8688f2f8da400116dd6fe193d
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PENK DCN FBLN1 AGTR2 CCL8 FLRT2 PEX5L	1.42e-05	171	204	7	15cb4670ff4234ac46aea8a5911138d6913c4482
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	UBTD2 TYRO3 FCGBP NEURL1B RFC4 ADGRG6 DEPDC1B	1.42e-05	171	204	7	0eea035fde32cc2a75a0d4227911edb5d54ed47e
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	THSD4 ASTN2 GGACT FLRT2 GALNT9 SCUBE3 ZMYM3	1.53e-05	173	204	7	b43817a6b1ed8d6b5366702343be4311c0d52d83
ToppCell	IIH-CD8-naive_CD4\|IIH / Condition, Cell_class and T cell subcluster	WDR81 USP19 CLCN7 SEC24B FLRT2 ARMC6 WDSUB1	1.53e-05	173	204	7	4f2843371d18af766c1892529ce286f56c956fde
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	THSD4 PENK DCN ACAN PDGFC SDK2 SCUBE3	1.84e-05	178	204	7	8591a40fced747ac16b3e8ebc7a22dfb3ad76da2
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APCDD1 DCN FBLN1 KCNE4 FLRT2 SDK2 LTBP2	1.84e-05	178	204	7	d348a9550db940d204706529759dc51e30506b5f
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN CCL8 P2RY12 ROR2 RNF17 ARFGEF3 LYPD3	1.84e-05	178	204	7	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN CCL8 P2RY12 ROR2 RNF17 ARFGEF3 LYPD3	1.84e-05	178	204	7	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APCDD1 DCN FBLN1 KCNE4 FLRT2 SDK2 LTBP2	1.84e-05	178	204	7	27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee
ToppCell	droplet-Fat-Bat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 NDE1 THSD1 CCNJL WSCD1 SDK2 MCM9	1.91e-05	179	204	7	e6224864eb76a2e9c1fc0c61513d9e936bb5c72c
ToppCell	droplet-Fat-Bat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 NDE1 THSD1 CCNJL WSCD1 SDK2 MCM9	1.91e-05	179	204	7	dfe110add7228cd834b35916cbcc849769a01bb9
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 DCN FBLN1 INSC ROR2 ADGRG6 LTBP2	1.91e-05	179	204	7	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	droplet-Fat-Bat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 NDE1 THSD1 CCNJL WSCD1 SDK2 MCM9	1.91e-05	179	204	7	9863ab3ceb160a4b1d9790033a4ac48845863d65
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THSD4 KCNMA1 FLRT2 PDGFC ROR2 ADGRG6 LTBP2	2.05e-05	181	204	7	25915e2500430a902db37d79a749ce2990b69810
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	NOL4 PLPPR1 GP2 GRIN2A CUBN DPF3 LTBP2	2.05e-05	181	204	7	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UBTD2 PLPPR1 FREM2 ARHGAP31 ROR2 ADGRG6 PDGFD	2.20e-05	183	204	7	f8b636391f752e379a5c5575fd898bdf0907a3b8
ToppCell	mild-Myeloid-mDC\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PLXNB2 CYFIP1 ARHGAP31 SLC25A5 ADGRG6 CD1C LMNA	2.28e-05	184	204	7	8b37c00d59d9992d3b43268991da7bb94646c70e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 PLPPR1 F11 ASTN2 GP2 USP24 ARFGEF3	2.36e-05	185	204	7	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2\|TCGA-Kidney / Sample_Type by Project: Shred V9	THSD1 KCNE4 ACAN NEURL1B DCHS1 LTBP2 PEAK1	2.44e-05	186	204	7	1e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 PLPPR1 F11 ASTN2 GP2 USP24 ARFGEF3	2.44e-05	186	204	7	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FREM2 KCNMA1 PDGFC AKAP6 SLC25A4 LAMA5 LTBP2	2.53e-05	187	204	7	3912bbb610a4a84791e9bda92a2d57a52c31d29e
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 LRRK2 ARHGAP31 KCNMA1 ROR2 USP24 ZDBF2	2.62e-05	188	204	7	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 LRRK2 ARHGAP31 KCNMA1 ROR2 USP24 ZDBF2	2.62e-05	188	204	7	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 LRRK2 ARHGAP31 KCNMA1 ROR2 USP24 ZDBF2	2.62e-05	188	204	7	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	WDR81 USP12 ARMC6 CCDC127 STK16 LMNA EDRF1	2.71e-05	189	204	7	8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|368C / Donor, Lineage, Cell class and subclass (all cells)	USP9Y INSC GGACT RFC4 TBCCD1 TRMT44 DCLRE1C	2.71e-05	189	204	7	610d7cc1fc923dbd67d3b71f94d529a658982f87
ToppCell	Fibroblast-C\|World / shred on cell class and cell subclass (v4)	PENK DCN FBLN1 KCNE4 AGTR2 FLRT2 LTBP2	2.71e-05	189	204	7	58e0400fbab5a0755504275aef5cf7986149abab
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B DLC1 PLA2G4A NEURL1B	2.80e-05	190	204	7	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN DLC1 ACAN KCNMA1 NEURL1B ROR2	2.80e-05	190	204	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B DLC1 PLA2G4A NEURL1B	2.80e-05	190	204	7	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RTEL1 THSD1 ASTN2 SNURF SLC25A6 MRPL38 PCDHGC3	2.80e-05	190	204	7	c41b71ecd49cc5a82be9dde79093490fd2196432
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 F11 GP2 SLC25A4 SLC25A6 ARFGEF3 LTBP2	2.89e-05	191	204	7	f631749ef1f2270133664cf5eb4cf545a8482bd3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B PLA2G4A NEURL1B GRIN2A	2.89e-05	191	204	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	USP9Y INSC GGACT RFC4 TBCCD1 TRMT44 HTT	2.89e-05	191	204	7	cadb7a9de16f4bb21606de0e25cddd2d748c7f0b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 ADRA1B PLA2G4A NEURL1B GRIN2A	2.89e-05	191	204	7	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PENK DCN FBLN1 KCNE4 AGTR2 FLRT2 LTBP2	2.99e-05	192	204	7	19b94f254d51b9bda3d9b7c6f85e27ecb58409c8
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PENK DCN FBLN1 KCNE4 AGTR2 FLRT2 LTBP2	2.99e-05	192	204	7	ad48c941a3ddfd9a5146bafc2209da577bb50531
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB6 PENK DCN PLPPR1 ASTN2 TRB ADGRG6	2.99e-05	192	204	7	dc40ef2341e5d6a6d479f140e023fe1bf687928d
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN FBLN1 CYFIP1 P2RY12 DOCK8 USP24 PROS1	3.09e-05	193	204	7	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN FBLN1 CYFIP1 P2RY12 DOCK8 USP24 PROS1	3.09e-05	193	204	7	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN FBLN1 CYFIP1 P2RY12 DOCK8 USP24 PROS1	3.09e-05	193	204	7	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN FBLN1 CYFIP1 P2RY12 DOCK8 USP24 PROS1	3.09e-05	193	204	7	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB6 PENK DCN ASTN2 TRB PTPRU ADGRG6	3.09e-05	193	204	7	c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	LRRK2 DCN DLC1 INSC ACAN PLA2G4A ADGRG6	3.09e-05	193	204	7	e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB6 THSD1 DCN FBLN1 KCNE4 ROR2 TECTA	3.09e-05	193	204	7	7c0d84b92470bfda2db1e5007feee7c1235a0a78
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	LRRK2 DCN DLC1 INSC ACAN PLA2G4A ADGRG6	3.09e-05	193	204	7	b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A CACNA1I ATP10D	3.20e-05	194	204	7	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A CACNA1I ATP10D	3.20e-05	194	204	7	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar-AT2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 USP19 DLC1 SLAIN1 CCNJL RPUSD2 EDEM1	3.20e-05	194	204	7	a4f7cd507eba40985d82635bbae28c7f5703f883
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar-AT2-AT2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 USP19 DLC1 SLAIN1 CCNJL RPUSD2 EDEM1	3.20e-05	194	204	7	df835578d86a49ae5af5632152fbab9548c0a448
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 USP19 DLC1 SLAIN1 CCNJL RPUSD2 EDEM1	3.20e-05	194	204	7	0715f2d55f4a6d2edda1b3dc52f12d25ce59eb10
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	APCDD1 DCN INSC KCNMA1 SDK2 PDGFD PCDHGC3	3.20e-05	194	204	7	292ce9021678534c9eedb367b9772a9d976208a8
ToppCell	facs-Skin-nan-18m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD1 FBLN1 GGACT FLRT2 STPG4 LMNA LTBP2	3.30e-05	195	204	7	ba7cb80deb872c9184769f0dd57855c3c6a432bf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DCN FBLN1 DLC1 PLA2G4A GRIN2A ATP10D	3.41e-05	196	204	7	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD4 DCN TYRO3 QSOX1 FBLN1 ARID5B ROR2	3.52e-05	197	204	7	ad6c200a193a15360d17463e18a465ce1b90b8da
Drug	Clodronate	SLC25A4 SLC25A5 SLC25A6	6.78e-07	3	201	3	DB00720
Drug	Bromperidol [10457-90-6]; Up 200; 9.6uM; HL60; HG-U133A	CHST5 NDE1 ACAN ANKRD40 GP2 CPOX CUBN LIMK2 PRKAR2A HTT S1PR4	1.59e-06	198	201	11	1723_UP
Drug	dehydroabietylamine	SLC25A4 SLC25A5 SLC25A6	2.69e-06	4	201	3	ctd:C000600819
Drug	Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	FBLN1 ACAN KCNMA1 AKAP6 NR3C1 TECTA CRYGC LMNA DPF3 PDGFD	9.68e-06	195	201	10	2225_UP
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A	THSD4 CHST5 DLC1 ACAN CACNA1I FLRT2 CCL23 WSCD1 CUBN SOS2	1.01e-05	196	201	10	2263_UP
Drug	Metolazone [17560-51-9]; Up 200; 11uM; HL60; HG-U133A	ATR RTEL1 USP19 ACAN BRPF1 SNURF ARMC6 IDH3G PRKAR2A SOS2	1.11e-05	198	201	10	2014_UP
Disease	autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology)	SLC25A4 SLC25A5 SLC25A6	1.20e-06	4	199	3	DOID:0111517 (implicated_via_orthology)
Disease	hypertrophic cardiomyopathy (implicated_via_orthology)	XIRP1 SLC25A4 SLC25A5 SLC25A6	4.18e-05	29	199	4	DOID:11984 (implicated_via_orthology)
Disease	cataract 2 multiple types (implicated_via_orthology)	CRYGC CRYGD	4.53e-05	2	199	2	DOID:0110235 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	NDE1 KCNMA1 SLC25A4 SLC25A5 SLC25A6 GRIN2A SBF2	1.25e-04	163	199	7	DOID:1826 (implicated_via_orthology)
Disease	anorexia nervosa (is_implicated_in)	AKAP6 NR3C1	1.35e-04	3	199	2	DOID:8689 (is_implicated_in)
Disease	CATARACT, AUTOSOMAL DOMINANT	CRYGC CRYGD	2.69e-04	4	199	2	C1858679
Disease	Colorectal Carcinoma	EPHB6 LAMA1 DLC1 AKAP6 GRIN2A PTPRU CUBN PEX5L PDGFD DCHS1 SNRNP200 EDRF1 EPHA1 PROS1	3.16e-04	702	199	14	C0009402
Disease	hydrocephalus (is_implicated_in)	WDR81 SMARCC1	6.67e-04	6	199	2	DOID:10908 (is_implicated_in)
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	GBA2 ATP10D	9.29e-04	7	199	2	EFO_0800551
Disease	glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement	GBA2 ATP10D	9.29e-04	7	199	2	EFO_0800520
Disease	cholesteryl ester 16:2 measurement	DPF3 LTBP2	9.29e-04	7	199	2	EFO_0021435
Disease	urate measurement, bone density	THSD4 FBLN1 ARID5B KCNMA1 AKAP6 LAMA5 OGDH GALNT9 HELZ2 PRKAR2A PRKDC PEAK1	1.08e-03	619	199	12	EFO_0003923, EFO_0004531
Disease	cerebrovascular disease (is_implicated_in)	P2RY12 LMNA	1.23e-03	8	199	2	DOID:6713 (is_implicated_in)
Disease	hemoglobin A2 measurement	HBS1L OR51V1	1.23e-03	8	199	2	EFO_0005845
Disease	platelet measurement	HBS1L LRRK2 SIRPB1 SIRPD MICB TASOR P2RY12 DOCK8	1.41e-03	315	199	8	EFO_0005036
Disease	velocardiofacial syndrome (implicated_via_orthology)	UFD1 MAPK1	1.58e-03	9	199	2	DOID:12583 (implicated_via_orthology)
Disease	CATARACT, COPPOCK-LIKE	CRYGC CRYGD	1.58e-03	9	199	2	C1852438
Disease	Cataract microcornea syndrome	CRYGC CRYGD	1.58e-03	9	199	2	C1861829
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCC1 SMARCC2	1.58e-03	9	199	2	DOID:0050340 (implicated_via_orthology)
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCC1 SMARCC2	1.58e-03	9	199	2	DOID:1925 (implicated_via_orthology)
Disease	signal-regulatory protein beta-1 measurement	SIRPB1 SIRPD	1.58e-03	9	199	2	EFO_0802069
Disease	Cataract, Pulverulent	CRYGC CRYGD	1.58e-03	9	199	2	C1833118
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	PEF1 CACNA1I NR1D2 AKAP6 GRIN2A PTPRU OGDH MSL2 DPF3	1.61e-03	398	199	9	EFO_0003756, EFO_0003888, EFO_0004337
Disease	mitochondrial metabolism disease (implicated_via_orthology)	SLC25A4 SLC25A5 SLC25A6	1.69e-03	35	199	3	DOID:700 (implicated_via_orthology)
Disease	schizophrenia (is_implicated_in)	CYFIP1 UFD1 CACNA1I GRIN2A	1.94e-03	78	199	4	DOID:5419 (is_implicated_in)
Disease	4-vinylphenol sulfate measurement	CPOX SOS2	1.97e-03	10	199	2	EFO_0021149
Disease	alcohol use disorder (implicated_via_orthology)	ADRA1B KCNMA1 JMJD7 DPF3 SMARCC1 SMARCC2	2.15e-03	195	199	6	DOID:1574 (implicated_via_orthology)
Disease	Hodgkins lymphoma	HBS1L FCGBP CACNA1I PDGFD	2.33e-03	82	199	4	EFO_0000183
Disease	Diabetic Cardiomyopathies	AGTR2 SLC25A4	2.39e-03	11	199	2	C0853897
Disease	quality of life during menstruation measurement, dysmenorrheic pain measurement	PLPPR1 GRIN2A	2.39e-03	11	199	2	EFO_0007889, EFO_0009366
Disease	Nerve Degeneration	LRRK2 TSC2 ADRA1B MAPK1	2.43e-03	83	199	4	C0027746
Disease	colorectal health	XIRP1 PKD1L1 ASTN2 FBXO39 GP2 DSG1	2.50e-03	201	199	6	EFO_0008460
Disease	Combined immunodeficiency	DOCK8 DCLRE1C PRKDC	2.67e-03	41	199	3	C0494261
Disease	neurodegenerative disease (implicated_via_orthology)	LRRK2 UFD1 AFG3L2 OGDH HTT	3.09e-03	145	199	5	DOID:1289 (implicated_via_orthology)
Disease	systemic lupus erythematosus	SIRPB1 CD83 TYK2 SIRPD ARHGAP31 ARID5B PLD2 RSPH3 GTF2H1 TRMT44 DPF3 GALNT9 SCUBE3	3.16e-03	799	199	13	MONDO_0007915
Disease	Muscular Dystrophy, Facioscapulohumeral	DCN ACAN	3.36e-03	13	199	2	C0238288
Disease	Thrombus	TYRO3 P2RY12 PROS1	3.71e-03	46	199	3	C0087086
Disease	Pneumoconiosis	ATR ACAN	3.90e-03	14	199	2	C0032273
Disease	Bagassosis	ATR ACAN	3.90e-03	14	199	2	C0004681
Disease	Adenocarcinoma of large intestine	TYK2 DLC1 ROR2 PRKDC	4.11e-03	96	199	4	C1319315
Disease	venous thromboembolism	XIRP1 APCDD1 F11 DLC1 TMPRSS11D ASTN2 GRIN2A CPOX DEPDC1B	4.20e-03	460	199	9	EFO_0004286
Disease	overall survival, pancreatic carcinoma	ASTN2 GTF2H1 SBF2	4.43e-03	49	199	3	EFO_0000638, EFO_0002618
Disease	Thrombosis	TYRO3 P2RY12 PROS1	4.43e-03	49	199	3	C0040053
Disease	malaria	C4orf17 ASTN2 OR51F1 OR51V1	5.10e-03	102	199	4	EFO_0001068
Disease	Dermatitis	PLA2G4A DSG1	5.10e-03	16	199	2	C0011603
Disease	Monogenic diabetes	KLF11 LMNA	5.10e-03	16	199	2	C3888631
Disease	platelet crit	HBS1L RTEL1 LRRK2 SIRPB1 TYK2 SIRPD MICB ARID5B PDGFC LAMA5 CUBN MRPS18A DCHS1 S1PR4	5.40e-03	952	199	14	EFO_0007985
Disease	pulmonary function measurement, FEV/FEC ratio	THSD4 CCL23 ADGRG6	5.52e-03	53	199	3	EFO_0003892, EFO_0004713
Disease	glomerulonephritis (implicated_via_orthology)	AGTR2 PDGFD	5.76e-03	17	199	2	DOID:2921 (implicated_via_orthology)
Disease	glucose homeostasis measurement, acute insulin response measurement	ASTN2 SDK2	6.45e-03	18	199	2	EFO_0006831, EFO_0006896
Disease	Nuclear non-senile cataract	CRYGC CRYGD	6.45e-03	18	199	2	C1112705
Disease	Nuclear cataract	CRYGC CRYGD	6.45e-03	18	199	2	C0392557
Disease	mortality	LINC01558 MICB KCNMA1 USP12 SLC25A4	6.49e-03	173	199	5	EFO_0004352
Disease	Rheumatoid Arthritis	CD83 TYK2 ACAN ARID5B CCL8	6.65e-03	174	199	5	C0003873

Protein segments in the cluster

Peptide	Gene	Start	Entry
RLELAAPSQTSVYFC	TRBV6-6	96	A0A0A6YYG2
LLSQPVTYQAFRECT	BCL2L13	126	Q9BXK5
SVRVFYQRCPETLNG	EPHA1	196	P21709
TSLCFVYPLDFARTR	SLC25A6	126	P12236
RSIPCSLLESYFETN	CCL23	61	P55773
TCLSREPFPASNYIR	CFAP61	1101	Q8NHU2
GEQPCLRTLYRFVTT	AFG3L2	31	Q9Y4W6
ASRICFYNATNPLVT	ADGRG6	556	Q86SQ4
RPQEVSAYLTRFCDQ	ARMC6	106	Q6NXE6
NRERCQNLVSSDYPV	ABHD18	41	Q0P651
ACLSSLPTFYFRDVR	AGTR2	171	P50052
TSLCFVYPLDFARTR	SLC25A5	126	P05141
FQTPVQDLCLAYRDS	CCNJL	346	Q8IV13
SSLKYQTRCIRAFPN	BUB3	176	O43684
ACNRHLRTPTNYFIV	ADRA1B	71	P35368
FCRQISPEEFEYQRS	DEPDC1B	431	Q8WUY9
TRFVTYFCEQVLPNL	API5	256	Q9BZZ5
FRNAASTLTERPCYN	ANKRD40	346	Q6AI12
ALSLQSFCPTTRRYL	AMPD2	256	Q01433
SFCPTTRRYLQQLAE	AMPD2	261	Q01433
RSTYRICLVPLDAFN	FLRT2	486	O43155
IQSRVETVPYLFCRS	ASTN2	1286	O75129
AARAYQCTLRSRTPE	ATP10D	736	Q9P241
SCYLLFRNGSVSRVP	QSOX1	236	O00391
LDISRFRSSPTYRDC	LARGE2	671	Q8N3Y3
FRSSPTYRDCLQALK	LARGE2	676	Q8N3Y3
RVTAVPLDSYCNDRS	INO80	1016	Q9ULG1
CISPSTAAQFIYSRR	HBS1L	31	Q9Y450
ATCSYRLVRPADINF	PENK	31	P01210
LTEEVRLYSCTPRNF	PDGFC	241	Q9NRA1
RLYSCTPRNFSVSIR	PDGFC	246	Q9NRA1
NERPYSLKIRNTTSC	CD83	86	Q01151
CYNGSTNRFVRTVLP	CYFIP1	856	Q7L576
ISPFEHQTYCQRTLR	MAPK1	56	P28482
LRTAAALDREQCPSY	DCHS1	1911	Q96JQ0
IYPNCSSGVVRAQSR	KCNE4	6	Q8WWG9
PAEYNLRSRTVLCGT	LMNA	576	P02545
PALSRCSQLTTFYFR	PRAMEF17	371	Q5VTA0
YSTPQTLANRDRCRV	KCNMA1	1086	Q12791
QAVQDSSLPRVARCY	SBF2	1161	Q86WG5
SYNSRLCAERSVRLP	DPF3	26	Q92784
SVSARQPLCQYRAAT	EDRF1	1011	Q3B7T1
RCSSSYSQQIFRPCD	LIMK2	316	P53671
PSYSQAQALRCTVRA	JMJD7	251	P0C870
IVLFSVYCRLQGRSQ	GALNT9	21	Q9HCQ5
TLDSIYFQPGSRVQC	FREM2	2466	Q5SZK8
RCNYTEAFQTQTRPS	IL17RB	101	Q9NRM6
SNFTCLVAIGRLQPY	ARNTL2	341	Q8WYA1
TVAFVLIYSSRDCQP	CLCN7	426	P51798
RYALQCRFSPDSTLL	MLST8	221	Q9BVC4
SCTPRNYSVNIREEL	PDGFD	271	Q9GZP0
SFQPERYSVSTRIVC	PLXNB2	846	O15031
CDPLRYTTILTNSRI	OR51F1	136	A6NGY5
CNPLRYSSILTNSRI	OR51V1	136	Q9H2C8
RSPYSRGLQQLASCL	PEAK1	1631	Q9H792
FIRSRYNLGISCINL	PEX5L	541	Q8IYB4
PSTFRCVYVRSAIQL	DCN	341	P07585
ITRYQETFNVIERCP	ECH1	146	Q13011
IPIRSISLRSCYFSD	FBXO39	306	Q8N4B4
TSRFNLVLRNCYATP	GP2	391	P55259
FYRDAVLQRCSPNLQ	LRRK2	916	Q5S007
FESCPALYQRTVLRV	GGACT	81	Q9BVM4
RSYRQSSANLLCFAP	NR3C1	611	P04150
PVSFSTFRRCNYPVR	LHFPL1	41	Q86WI0
ITVTCRASSFYPRNI	MICB	221	Q29980
QTFVSCQEQRLTYLP	ASIC4	276	Q96FT7
RVTEACTYRPSAQQS	LAMA5	1026	O15230
QNTLRSCDPVFYRQV	PCDHGC3	786	Q9UN70
RIPYTLSQTRDVFDC	P2RY12	256	Q9H244
INRLLPYFRQSLSCC	MSL2	31	Q9HCI7
RDNCPVTRLLSFNYA	OOSP4B	41	A0A2R8Y4Y8
PEICQEYSGTLRRNS	DSG1	666	Q02413
NLSPQFTQLLVSRYC	PEF1	216	Q9UBV8
FTQLLVSRYCPRSAN	PEF1	221	Q9UBV8
CNSDLRNKTYFSPRI	LYPD3	221	O95274
YERTVFLRCVANSNP	MDGA2	151	Q7Z553
FLRCVANSNPPVRYS	MDGA2	156	Q7Z553
PTRYSLTFEEAQQAC	ACAN	486	P16112
RAEQDLYRCVSQAPR	PTPRU	256	Q92729
CPENYRRSAATLQQE	FBLN1	556	P23142
NRPAAARTFQQIRCY	OGDH	26	Q02218
ARTFQQIRCYSAPVA	OGDH	31	Q02218
RFDIEVTPNCTSNYL	CUBN	2266	O60494
DSYSPQAQSRCVFLL	ATR	626	Q13535
RLLTSDFPYGRSCQI	LINC01558	21	Q9Y6Z2
LQPYLSRCNSARVDS	CRYGD	26	P07320
FSPYLISCTVINRLR	HTT	1701	P42858
CREVAARYPQITFEN	IDH3G	236	P51553
TTFCDPRFYQIPSRE	DCLRE1C	166	Q96SD1
LPQLCDFTVADTRRY	DOCK8	1226	Q8NF50
PLRSAYLSCLQREEN	CCDC127	136	Q96BQ5
LTERQNIYCSLFLPR	CCDC127	166	Q96BQ5
TVYNLIRSTCPRFLL	CD1C	176	P29017
LSRLRPASANSCEYL	C16orf96	936	A6NNT2
QTPEAYCQQRVFRSL	GBA2	861	Q9HCG7
ATCQAVLSPSEYFRQ	FCGBP	5061	Q9Y6R7
CTFALPSELERSYQR	CUL1	551	Q13616
CTFDVRNLLPNRSYK	FNDC11	266	Q9BVV2
YPDITNFLSVDCRTR	ARFGEF3	571	Q5TH69
YLFSPENRFRVLCQT	CACNA1I	1151	Q9P0X4
VSARSIQEYNLCPQR	C4orf17	336	Q53FE4
QRLESYTRITNIQCP	CCL8	46	P80075
YATRQFPSLEHRNIC	F11	151	P03951
GSNRCTNPTYTLIIR	APCDD1	111	Q8J025
RSVSYCPLRQESSTQ	C17orf50	66	Q8WW18
LQPYFSRCNSIRVES	CRYGB	26	P07316
SSNCNRVPDERRYSL	EDEM1	626	Q92611
PRSSEVYAQLCNVAR	LTBP2	1626	Q14767
QDSFRCLYPQALRTL	INSC	291	Q1MX18
PSRFNRRVSVCAETY	PRKAR2A	91	P13861
NCVPQVDFSRRRNYV	KLF11	381	O14901
SIFCSPRQTNYIRSL	KRTAP15-1	81	Q3LI76
YLTQQCIPFTISQAR	C2orf81	76	A6NN90
LQPYFSRCNSIRVES	CRYGC	26	P07315
NRSHLYNTVRLFTPC	GDF9	106	O60383
YNTVRLFTPCTRHKQ	GDF9	111	O60383
SFCAQENVQRYPEIR	DNAJC10	621	Q8IXB1
CRVIPSRFLERQTYN	HELZ2	2131	Q9BYK8
AYRPCAQRASILFFV	DNAH2	3606	Q9P225
RSCRTYINPFVSFID	SEC24B	606	O95487
ETCQTYERPIAFTAR	SCUBE3	876	Q8IX30
VPARSYQFRLCAVND	SDK2	656	Q58EX2
AVNPIIYSFRSREVC	S1PR4	301	O95977
FRFVQSCARAVVPSY	CPOX	351	P36551
GLNLYTCSSRRPINR	PKD1L1	1536	Q8TDX9
ERTFTYPLSCIRSQP	C18orf63	261	Q68DL7
RRLNSAVECVPYTQA	MOCS3	146	O95396
CPRNSTFTEHLYRII	MCMBP	396	Q9BTE3
RSNPFYDRTCNNEVV	MED6	36	O75586
VSRLSCDNFTLNRIY	OR56A1	191	Q8NGH5
IEYRRQNPSRCSVSL	PLA2G4A	716	P47712
QSFLLDTQYRRSCAV	FAM149B1	531	Q96BN6
FSNAYTQRVCDRVPI	NR1D2	346	Q14995
TYFCLIRNLQPTLSD	MCM9	526	Q9NXL9
YPDSSQSRFCIVLQI	RNF139	41	Q8WU17
RCLQVLPERYSSLET	PGGT1B	31	P53609
LSYNGQSSVVRCRPL	RPUSD2	351	Q8IZ73
ARRAQRPTATYCAVT	RPUSD3	161	Q6P087
QRFSQTCTDLTGRPY	RTEL1	1126	Q9NZ71
LNPAFCSVELRTTAY	TAS2R45	71	P59539
NYVSRIIEPLTSRCS	RFC4	181	P35249
IPVIAARSSYNCRFF	TRMT44	431	Q8IYL2
PRRCYVLSSSQNNLA	SOS2	1271	Q07890
AQRCTISYRAPELFS	STK16	191	O75716
LNRTFPFSLQYICRA	SOCS5	476	O75159
SADRDCIRAYQPQIS	LAMA1	2121	P25391
RLFSYTCPAVLRSFA	EPHB6	226	O15197
QRIYAFCTRLLTLPT	PIK3R6	96	Q5UE93
SSIRECRRSPSSQYF	SLAIN1	356	Q8ND83
RYSYQLLQCDSPRTE	SETD5	1236	Q9C0A6
VGSPLLRDNVCYSRT	MRPS18A	176	Q9NVS2
TRLEARTYRPNVELC	TEKT2	316	Q9UIF3
LRRGTDPATLYCINF	WDR45	231	Q9Y484
SDLCRQEYTIARSNP	ROR2	261	Q01974
ASLRDVFQLYCSLSP	NPRL2	276	Q8WTW4
PYIVHRCRQSINFSL	PI4KB	196	Q9UBF8
NTQRSYSIIPCFIFV	PLPPR1	6	Q8TBJ4
RQSTNAYPDLRSCVN	PROS1	101	P07225
DPFTSRQSLQALACY	RIC8A	81	Q9NPQ8
SRCRNSYTEQELKPL	DLC1	1291	Q96QB1
NPQEYLTSTACRRNL	SMARCC1	501	Q92922
NPQEYLTSTACRRNL	SMARCC2	476	Q8TAQ2
IDSCRRQFPEYQERA	NOL4	441	O94818
QCAVLYTTISGQRRL	SEC24D	746	O94855
EPTSVTNFNYRRACL	TASOR	136	Q9UK61
LVYRNDCSLPRSSSD	BRPF1	986	P55201
RTIRDCFNYNEDSPT	AKAP6	371	Q13023
TSLCFVYPLDFARTR	SLC25A4	126	P12235
VSRNPQILYCRDTFD	ARID5B	216	Q14865
TRQPFSLAREACRSY	CHST5	176	Q9GZS9
PSLRTYCDLNQIIRT	RNF17	251	Q9BXT8
ASLSNQECQLYPRRS	SNURF	31	Q9Y675
TCQVSNFYPRGLQLT	SIRPB1	271	O00241
YLLARQCLQTSSLPF	TECTA	346	O75443
RVTSTSRFLNPYVVC	TMPRSS11D	6	O60235
ALPCQRSRYRDSLTQ	RSPH3	166	Q86UC2
CPFQEKIRRQYLSTN	GTF2H1	506	P32780
YTACARLPNDRSSQR	USP19	1166	O94966
RIISSDVYTAPACQR	ZSWIM5	506	Q9P217
RPSPCYQLAQRTFRT	MRPL38	286	Q96DV4
SCVFRSTVQRFPTTY	STPG4	156	Q8N801
VIPCLRTQYQLSRAD	TOMT	196	Q8WZ04
DTSLYNTPCVLDLQR	STYXL2	106	Q5VZP5
RQAPAYSSRTRTCEQ	THSD1	676	Q9NS62
PNSGYECQLRLRLST	UBTD2	146	Q8WUN7
CNGVTFTQRPIRLYE	NEURL1B	66	A8MQ27
NSVLQALYFCRPFRE	USP12	51	O75317
TPVRAYDLRSSSCLQ	ZDBF2	2321	Q9HCK1
LPTHLFRQYSCLRSQ	TTC41P	76	Q6P2S7
SEQTCRRFYPVQISS	TMPRSS9	976	Q7Z410
CLSALPERNSTNYFV	SIRPD	166	Q9H106
QRLETSTSCFYQPQR	ARHGAP31	1416	Q2M1Z3
STSCFYQPQRRSVIL	ARHGAP31	1421	Q2M1Z3
NVSNRFSEYLLECPS	USP9Y	2096	O00507
EQPALNDSRYCLSSR	TRB	201	P0DTU4
CSQRALQLRTYSVVP	PRKDC	3781	P78527
DVARFCNRYPNIELS	SNRNP200	2006	O75643
IPRVFQNRFSTQYRC	UFD1	11	Q92890
TRQGVYSICLQLARF	USP24	1231	Q9UPU5
PSAEIRRVACDQLYT	USP24	1446	Q9UPU5
RCNESFIYLLSPLRS	TBCCD1	336	Q9NVR7
YQTPVQDTRCTDRRF	WSCD1	331	Q658N2
TRYVTTCAFAPNTLL	WDSUB1	281	Q8N9V3
VYANRSLTVQPYRCQ	THSD4	706	Q6ZMP0
RVLLTFCNQYGARLS	RIPOR1	991	Q6ZS17
SRCTYLNILLQTRSP	PPP1R10	46	Q96QC0
IYEQIFRCLPSNATR	PLD2	856	O14939
APSTRRQETSREYLC	XIRP1	1641	Q702N8
PELYASVCAQTRRAR	SIT1	166	Q9Y3P8
FTCLLRDLVPATNYS	TYRO3	281	Q06418
RLLTSCYVGPTRQQF	WDR81	1251	Q562E7
EFYLSKCPESLRTRN	ZMYM3	1301	Q14202
RQRICEEAAYSNPSL	TSC2	1751	P49815
SQCLTYEPTQRPSFR	TYK2	846	P29597
TPRVLNSCSNRRVYK	GRIN2A	1441	Q12879
LASCRNLVYDQSPNR	NDE1	271	Q9NXR1